Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
B Zeng, L Gao, Q Zhou, K Yu, F Sun - BMC medicine, 2022 - Springer
Background It was urgent and necessary to synthesize the evidence for vaccine
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
effectiveness (VE) against SARS-CoV-2 variants of concern (VOC). We conducted a …
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
WY Au, PPH Cheung - Bmj, 2022 - bmj.com
Objective To evaluate the effectiveness of heterologous and homologous covid-19 vaccine
regimens with and without boosting in preventing covid-19 related infection, hospital …
regimens with and without boosting in preventing covid-19 related infection, hospital …
[HTML][HTML] Antibody evasion of SARS-CoV-2 Omicron BA. 1, BA. 1.1, BA. 2, and BA. 3 sub-lineages
Summary The SARS-CoV-2 Omicron variant has evolved into four sub-lineages—BA. 1, BA.
1.1, BA. 2, and BA. 3—with BA. 2 becoming dominant worldwide. We and others have …
1.1, BA. 2, and BA. 3—with BA. 2 becoming dominant worldwide. We and others have …
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
K Rahmani, R Shavaleh, M Forouhi… - Frontiers in public …, 2022 - frontiersin.org
Background Vaccination, one of the most important and effective ways of preventing
infectious diseases, has recently been used to control the COVID-19 pandemic. The present …
infectious diseases, has recently been used to control the COVID-19 pandemic. The present …
A systematic review of coronavirus disease 2019 vaccine efficacy and effectiveness against severe acute respiratory syndrome coronavirus 2 infection and disease
Billions of doses of coronavirus disease 2019 (COVID-19) vaccines have been administered
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
globally, dramatically reducing severe acute respiratory syndrome coronavirus 2 (SARS …
COVID-19 vaccine strategies must focus on severe disease and global equity
In September, 2020, the WHO Prioritisation Roadmap for COVID-19 vaccines gave priority to
prevention of severe disease and the highest risk groups. In July, 2021, the revised …
prevention of severe disease and the highest risk groups. In July, 2021, the revised …
SARS-CoV-2 variants increase kinetic stability of open spike conformations as an evolutionary strategy
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs)
harbor mutations in the spike (S) glycoprotein that confer more efficient transmission and …
harbor mutations in the spike (S) glycoprotein that confer more efficient transmission and …
[HTML][HTML] Covid-19: virology, variants, and vaccines
Abstract As of 25 January 2022, over 349 million individuals have received a confirmed
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
diagnosis of covid-19, with over 5.59 million confirmed deaths associated with the SARS …
A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and disease
Billions of doses of COVID-19 vaccines have been administered globally, dramatically
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
reducing SARS-CoV-2 incidence and severity in some settings. Many studies suggest …
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells
A Nicolas, G Sannier, M Dubé, M Nayrac, A Tauzin… - IScience, 2023 - cell.com
Spacing the first two doses of SARS-CoV-2 mRNA vaccines beyond 3–4 weeks raised initial
concerns about vaccine efficacy. While studies have since shown that long-interval …
concerns about vaccine efficacy. While studies have since shown that long-interval …